Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Sickle Cell
•
Benign Hematology
How would you manage iron overload in sickle cell patients with cirrhosis?
How does your management change if the patient has concurrent renal insufficiency?
Related Questions
How long would you continue chronic transfusion therapy for adult sickle cell patients who have had a stroke?
What hydroxyurea dose do you target for HbSC disease?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Is there specific data on using luspatercept for sickle beta+ thalassemia with transfusion-dependent anemia?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Would you consider continuing or re-trialing hydroxyurea for sickle cell patients after development of a leg ulcer?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
How frequently would you consider IV iron treatment for ongoing iron loss and severe iron deficiency anemia?
For mild to moderate hemophilia B, do you routinely screen for inhibitors?